SB
SBC Medical Group Holdings Incorporated
SBC · NASDAQ
$4.85 -3.77% (-$0.19)
1M +14.12%
Market Cap $498.8M
P/E Ratio 10.17x
Div. Yield -
ROE 19.31%
Piotroski F-Score Moderate
6/9Valuation
94 /100
Cheap EV/EBITDA 4.74x
P/S 2.85x
P/B 1.89x
Growth
62 /100
Stable Rev. growth 0.11%
Book val. growth 33.12%
EPS growth 99.79%
Profitability
100 /100
Strong Net margin 27.99%
Op. margin 37.34%
FCF margin 42.79%
Quality
74 /100
Excellent ROE 19.31%
ROA 12.06%
Asset turnover 0.43x
Debt
100 /100
Low Current ratio 3.31x
Int. coverage 213.68x
Net debt/EBITDA -1.78x
Stability
60 /100
Moderate Rev. volatility 14.15%
EPS volatility 323.72%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SBC
Online
Sector
Industrials
Industry
Consulting Services
CEO
Yoshiyuki Aikawa
Employees
863
Headquarters
Irvine
Upcoming events
12 NOV
Earnings
Upcoming earnings report